Viewpoint: The outcome of Polymarket's recent lawsuit will determine the regulatory oversight of prediction markets in the United States
BlockBeats News, February 19th. A recent federal lawsuit filed by Polymarket against Massachusetts may determine whether the regulation of the U.S. prediction markets falls under federal or state jurisdiction. In the lawsuit, Polymarket argues that Congress has granted the exclusive regulatory authority over "event contracts" (such as sports, politics, and other prediction markets) to the U.S. Commodity Futures Trading Commission (CFTC), thereby prohibiting state governments from independently banning or regulating these platforms. The lawsuit aims to block potential enforcement actions by Massachusetts Attorney General Andrea Campbell, as the state court had previously issued a preliminary injunction against Polymarket's competitor, Kalshi, deeming its sports-related contracts as unlicensed sports betting.
The regulatory conflict between the U.S. federal government and states is escalating. Prediction market platforms claim that they fall under the CFTC-regulated derivatives market and can operate nationwide. However, states like Massachusetts and Nevada consider them a "sports betting loophole" to circumvent state gambling laws, leading to multiple lawsuits and injunctions. The outcome of Polymarket's appeal could reshape the regulatory framework of the U.S. prediction market, determining whether these platforms can evade state-level gambling regulations or must comply with different state rules. It may even potentially be appealed to the U.S. Supreme Court.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
European Stock Markets Closed Lower on Thursday, with Germany's DAX30 Index Falling by 1.72%
Major European stock indexes closed lower collectively
Solana payment volume increased by 755.3% year-on-year
Trending news
MoreAccording to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), as of February 27, 2026, JPMorgan Chase & Co. has significantly reduced its stake in telemedicine service provider Hims & Hers Health Inc. to 1.7%.
European Stock Markets Closed Lower on Thursday, with Germany's DAX30 Index Falling by 1.72%
